Value for money in health spending:
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Paris
2010
|
Schriftenreihe: | OEC health policy studies
|
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | Franz. Ausg. u.d.T.: Optimiser les dépenses de santé |
Beschreibung: | 200 S. graph. Darst. |
ISBN: | 9789264088801 9789264088818 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV036778394 | ||
003 | DE-604 | ||
005 | 20110401 | ||
007 | t | ||
008 | 101116s2010 d||| |||| 00||| eng d | ||
020 | |a 9789264088801 |9 978-92-64-08880-1 | ||
020 | |a 9789264088818 |9 978-92-64-08881-8 | ||
020 | |z 9264088814 |9 9264088814 | ||
020 | |z 9789264088801 |9 9789264088801 | ||
035 | |a (OCoLC)700360046 | ||
035 | |a (DE-599)BVBBV036778394 | ||
040 | |a DE-604 |b ger |e rakwb | ||
041 | 0 | |a eng | |
049 | |a DE-M382 |a DE-355 | ||
084 | |a QX 705 |0 (DE-625)142187: |2 rvk | ||
245 | 1 | 0 | |a Value for money in health spending |c OECD |
264 | 1 | |a Paris |c 2010 | |
300 | |a 200 S. |b graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 0 | |a OEC health policy studies | |
500 | |a Franz. Ausg. u.d.T.: Optimiser les dépenses de santé | ||
650 | 4 | |a Medical care, Cost of / OECD countries | |
650 | 4 | |a Medical care, Quality / OECD countries | |
650 | 4 | |a Health care reform / Economic aspects / OECD countries | |
650 | 4 | |a Medical economics / OECD countries | |
650 | 0 | 7 | |a Reform |0 (DE-588)4115716-3 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Kostendämpfung |0 (DE-588)4125598-7 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Gesundheitsausgaben |0 (DE-588)4210266-2 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Gesundheitsausgaben |0 (DE-588)4210266-2 |D s |
689 | 0 | 1 | |a Reform |0 (DE-588)4115716-3 |D s |
689 | 0 | 2 | |a Kostendämpfung |0 (DE-588)4125598-7 |D s |
689 | 0 | |C b |5 DE-604 | |
710 | 2 | |a OECD |e Sonstige |0 (DE-588)5157-3 |4 oth | |
856 | 4 | 2 | |m Digitalisierung UB Regensburg |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=020695099&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-020695099 |
Datensatz im Suchindex
_version_ | 1804143452535914496 |
---|---|
adam_text | TABLE
OF
CONTENTS
Table of Contents
Acronyms
.................................................................... 9
Executive Summary
.......................................................... 13
Chapter
1.
How Much is Too Much? Value for Money in Health Spending
....... 21
1.
Introduction
....................................................... 22
2.
Health care spending: developments over recent decades
................ 25
3.
Spending by type of health care services
............................... 30
4.
The drivers of health care spending
................................... 32
5.
Will financial sustainability be a problem in the future?
.................. 33
6.
Is fiscal sustainability a problem now?
................................. 36
7.
How can we ensure economic sustainability of health systems?
........... 38
8.
Conclusions
........................................................ 39
Notes
................................................................ 40
Bibliography
........................................................... 40
Chapter
2.
Policies for Health Care Systems when Money is Tight
.............. 43
1.
Introduction
....................................................... 44
2.
Overview of policy options
........................................... 46
3.
Supply-side policies intended to restrain expenditure and increase
cost efficiency
...................................................... 48
4.
Demand-side issues and policies
...................................... 67
5.
Conclusions
........................................................ 74
Notes
................................................................ 76
Bibliography
........................................................... 78
Chapter
3.
Rational Decision Making in Resource Allocation
................... 81
1.
Introduction
....................................................... 82
2.
The potential for enhanced efficiency
................................. 82
3.
EBM and
HTA
offer opportunities to rationalise health care provision
...... 87
4.
Health technology assessment
........................................ 88
5.
The current use of technology assessment in
OECD
countries
............. 90
6.
The impact of health technology assessment
........................... 96
7.
The future of health technology assessment
............................ 97
8.
Conclusions
........................................................ 100
Notes
................................................................ 101
Bibliography
........................................................... 101
TABLE
OF
CONTENTS
Chapter
4.
Improving Value for Money in Health by Paying for Performance
..... 105
1.
Introduction
....................................................... 106
2.
Difficulty in defining and measuring quality of care
..................... 106
3.
Pay for performance: a new paradigm
................................. 107
4.
Getting the design right in P4P: multiple agent problem
.................. 108
5.
Defining P4P
....................................................... 109
6.
P4P programme design framework
.................................... 110
7.
Rewarding providers
................................................ 112
8.
P4P programmes in
OECD
countries
................................... 113
9.
Conclusions
........................................................ 120
Notes
................................................................ 122
Bibliography
........................................................... 122
Chapter
5.
Improving Co-ordination of Care for Chronic Diseases to Achieve
Better Value for Money
........................................... 125
1.
Introduction
....................................................... 126
2.
Changing burden of disease in
OECD
countries
......................... 128
3.
Adapting health systems to meet the needs of the chronically ill
.......... 129
4.
OECD care
co-ordination survey
...................................... 129
5.
Models of care co-ordination
......................................... 132
6.
Disease management: a yet unproven tool for bending the cost curve
...... 135
7.
Improving the cost effectiveness of disease management
................ 143
8.
Achieving better returns from care co-ordination
....................... 147
9.
Conclusions
........................................................ 149
Notes
................................................................ 150
Bibliography
........................................................... 150
Chapter
6.
Drawing all the Benefits from Pharmaceutical Spending
............. 155
1.
Introduction
....................................................... 156
2.
Pharmaceutical spending in
OECD
countries
............................ 156
3.
Reimbursement and pricing policies in
OECD
countries
.................. 159
4.
Recent developments in reimbursement and pricing policies
............. 167
5.
Efforts to develop generic markets
.................................... 173
6.
Conclusions
........................................................ 179
Notes
................................................................ 180
Bibliography
........................................................... 181
Chapter
7.
Redesigning Health Systems with the Support of ICTs
............... 185
1.
Introduction
....................................................... 186
2.
What ICT can (and cannot) do for health care
........................... 187
3.
How can ICT improve value for money in health care
.................... 187
4.
Use of electronic health records is slow with a few exceptions
............ 192
5.
More widespread adoption requires overcoming several challenges
........ 194
6.
ICT is the foundation for a wider approach to improving health
system performance
................................................ 198
7.
Conclusions
........................................................ 198
Bibliography
........................................................... 199
TABLE
OF
CONTENTS
Tables
1.1. OECD
and selected national projections of public health and long-term
care spending,
2005
to
2050........................................... 35
2.1.
Policies for limiting spending in a period of budget restraint
.............. 47
2.2.
Trends in doctor numbers per
1000
population,
1980-2008................ 49
2.3.
Trends in nurse numbers per
1 000
population,
1980-2008................ 50
2.4.
Regulation of physician workforce
..................................... 53
2.5.
Regulation of hospital and high-tech equipment and activities
............ 55
2.6.
Regulation of prices/fees of physicians services
......................... 57
2.7.
Regulation of hospital prices for covered services
........................ 58
2.8.
Stringency of the budget constraint
.................................... 60
2.9.
Policies to control volumes of care
..................................... 65
2.10.
Exemptions from co-payments
........................................ 70
2.11.
Gate keeping
........................................................ 73
3.1.
Use of HTAinOECD countries
......................................... 92
4.1.
Pay-for-performance definitions
....................................... 110
4.2.
P4P programmes and measures in
OECD
countries
....................... 114
5.1.
Problems with care co-ordination in
OECD
countries
..................... 130
5.2.
Evaluation of US Medicare disease management initiatives
............... 138
6.1.
Policies to promote the use of generic drugs
............................ 174
7.1.
Current budget for ICT initiatives in three
OECD
countries
................ 192
7.2.
Total budget allocated by national government in two
OECD
countries
........ 192
7.3.
Measures to address lack of interoperability by country
.................. 196
Figures
1.1.
Average health spending as a share of gross domestic product (GDP)
across
OECD
countries
............................................... 26
1.2.
Annual growth in per capita health expenditure,
1993
to
2008............. 26
1.3.
Growth in total health expenditure and GDP in
OECD
countries,
1993
to
2008........................................................ 27
1.4.
Annual growth in total health spending and GDP,
1993
to
2008............ 27
1.5.
Per capita total spending on health in
1993
and annual growth in spending,
1993
to
2008........................................................ 29
1.6.
Ratio of private to public health spending growth,
1993
to
2008............ 29
1.7.
Contribution to health spending growth by main functions of health care,
2003
to
2008........................................................ 31
1.8.
Projections of public health and long-term care spending,
2005-50......... 33
1.9.
Forecast debt-to-GDP and general government financial balances,
2011..... 37
1.10.
Public spending on health as a share of total government spending,
2008...... 38
2.1.
Expenditure scenarios for health: the potential impact of reforms
......... 45
2.2.
Health professionals per
1000
population,
2008......................... 51
2.3.
Acute care hospital beds per
1000
population,
1995
and
2008............. 52
2.4.
Ratio of nurses to physicians,
1995
and
2008............................ 53
2.5.
Purchasing power parities (PPPs) for health goods and services,
2005....... 56
2.6.
Percentage of in-patient care in total health expenditure,
1980,1990,2000
and
2008............................................. 63
2.7.
Health care spending by component,
2008
(or most recent year)
........... 64
2.8.
Doctors consultations and density of physicians,
2008.................... 68
2.9.
Discharges per capita and number of beds,
2008......................... 69
2.10.
Out-of-pocket payments as a percentage of total health expenditure,
1990,
2000
and
2008............................................................ 71
3.1.
International variations in medical practice
............................. 83
TABLE
OF
CONTENTS
3.2.
Local variations
in medical practice
.................................... 86
4.1.
P4P programme framework
...........................................
Ill
4.2.
P4P payment models and implementation
.............................. 112
4.3.
Value Incentive Programme mechanisms in Korea
....................... 119
4.4.
Composite quality score of AMI
....................................... 119
5.1.
Improving outcomes in chronic illness
................................. 129
5.2.
Population management: more than care and case management
.......... 134
5.3.
Disease management programmes in Germany
......................... 139
5.4.
DMPs for type
2
diabetes programmes reduce hospital cost
............... 139
5.5.
Enrolment in DMP type
2
diabetes in Austria, May
2010................... 141
5.6.
Primary care depression
.............................................. 145
6.1.
Pharmaceutical spending is a share of total health expenditure
and GDP,
2008...................................................... 157
6.2.
Per capita pharmaceutical spending,
2008.............................. 157
6.3.
Pharmaceutical spending, by funding sources,
2007...................... 158
6.4.
Pharmaceutical spending growth,
2003
to
2008.......................... 159
6.5.
Typology of product-specific reimbursement and pricing agreements
...... 171
6.6.
Generic drug market shares in
2008.................................... 175
7.1.
The effects of
telemedicine
........................................... 190
7.2.
Use of Electronic Health Records in Finland, Norway
and the United States
................................................ 194
8
|
any_adam_object | 1 |
building | Verbundindex |
bvnumber | BV036778394 |
classification_rvk | QX 705 |
ctrlnum | (OCoLC)700360046 (DE-599)BVBBV036778394 |
discipline | Wirtschaftswissenschaften |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01847nam a2200469 c 4500</leader><controlfield tag="001">BV036778394</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20110401 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">101116s2010 d||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789264088801</subfield><subfield code="9">978-92-64-08880-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789264088818</subfield><subfield code="9">978-92-64-08881-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9264088814</subfield><subfield code="9">9264088814</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9789264088801</subfield><subfield code="9">9789264088801</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)700360046</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV036778394</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-M382</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QX 705</subfield><subfield code="0">(DE-625)142187:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Value for money in health spending</subfield><subfield code="c">OECD</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Paris</subfield><subfield code="c">2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">200 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">OEC health policy studies</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Franz. Ausg. u.d.T.: Optimiser les dépenses de santé</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical care, Cost of / OECD countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical care, Quality / OECD countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health care reform / Economic aspects / OECD countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical economics / OECD countries</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Reform</subfield><subfield code="0">(DE-588)4115716-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kostendämpfung</subfield><subfield code="0">(DE-588)4125598-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitsausgaben</subfield><subfield code="0">(DE-588)4210266-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Gesundheitsausgaben</subfield><subfield code="0">(DE-588)4210266-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Reform</subfield><subfield code="0">(DE-588)4115716-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Kostendämpfung</subfield><subfield code="0">(DE-588)4125598-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="C">b</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">OECD</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)5157-3</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Regensburg</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=020695099&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-020695099</subfield></datafield></record></collection> |
id | DE-604.BV036778394 |
illustrated | Illustrated |
indexdate | 2024-07-09T22:47:53Z |
institution | BVB |
institution_GND | (DE-588)5157-3 |
isbn | 9789264088801 9789264088818 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-020695099 |
oclc_num | 700360046 |
open_access_boolean | |
owner | DE-M382 DE-355 DE-BY-UBR |
owner_facet | DE-M382 DE-355 DE-BY-UBR |
physical | 200 S. graph. Darst. |
publishDate | 2010 |
publishDateSearch | 2010 |
publishDateSort | 2010 |
record_format | marc |
series2 | OEC health policy studies |
spelling | Value for money in health spending OECD Paris 2010 200 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier OEC health policy studies Franz. Ausg. u.d.T.: Optimiser les dépenses de santé Medical care, Cost of / OECD countries Medical care, Quality / OECD countries Health care reform / Economic aspects / OECD countries Medical economics / OECD countries Reform (DE-588)4115716-3 gnd rswk-swf Kostendämpfung (DE-588)4125598-7 gnd rswk-swf Gesundheitsausgaben (DE-588)4210266-2 gnd rswk-swf Gesundheitsausgaben (DE-588)4210266-2 s Reform (DE-588)4115716-3 s Kostendämpfung (DE-588)4125598-7 s b DE-604 OECD Sonstige (DE-588)5157-3 oth Digitalisierung UB Regensburg application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=020695099&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Value for money in health spending Medical care, Cost of / OECD countries Medical care, Quality / OECD countries Health care reform / Economic aspects / OECD countries Medical economics / OECD countries Reform (DE-588)4115716-3 gnd Kostendämpfung (DE-588)4125598-7 gnd Gesundheitsausgaben (DE-588)4210266-2 gnd |
subject_GND | (DE-588)4115716-3 (DE-588)4125598-7 (DE-588)4210266-2 |
title | Value for money in health spending |
title_auth | Value for money in health spending |
title_exact_search | Value for money in health spending |
title_full | Value for money in health spending OECD |
title_fullStr | Value for money in health spending OECD |
title_full_unstemmed | Value for money in health spending OECD |
title_short | Value for money in health spending |
title_sort | value for money in health spending |
topic | Medical care, Cost of / OECD countries Medical care, Quality / OECD countries Health care reform / Economic aspects / OECD countries Medical economics / OECD countries Reform (DE-588)4115716-3 gnd Kostendämpfung (DE-588)4125598-7 gnd Gesundheitsausgaben (DE-588)4210266-2 gnd |
topic_facet | Medical care, Cost of / OECD countries Medical care, Quality / OECD countries Health care reform / Economic aspects / OECD countries Medical economics / OECD countries Reform Kostendämpfung Gesundheitsausgaben |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=020695099&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT oecd valueformoneyinhealthspending |